Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001250853-14-000024
Filing Date
2014-01-22
Accepted
2014-01-22 14:29:22
Documents
1
Period of Report
2013-12-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3768
  Complete submission text file 0001250853-14-000024.txt   5377
Mailing Address 21900 BURBANK BLVD. THIRD FLOOR WOODLAND HILLS CA 91367
Business Address 21900 BURBANK BLVD. THIRD FLOOR WOODLAND HILLS CA 91367 818-992-3126
Lion Biotechnologies, Inc. (Issuer) CIK: 0001425205 (see all company filings)

EIN.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 4731 Arrangement of Transportation of Freight & Cargo

Mailing Address 21900 BURBANK BOULEVARD, 3RD FLOOR WOODLAND HILLS CA 91367
Business Address
Singh Manish (Reporting) CIK: 0001550588 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-53127 | Film No.: 14540026